In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media, Capital Equipment), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global in vitro fertilization market size was valued at USD 23.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.72% from 2023 to 2030. Rising repro tourism and the increasing cases of male and female infertility are the key factors driving the market growth. Infertility is one of the major health concerns faced by individuals globally. According to WHO, 8%-10% of couples globally suffer from infertility which is around 80 million couples worldwide. According to the American Pregnancy Association, male infertility accounts for 30% of infertility cases and contributes to around one-fifth of infertility cases. The average age of women and men getting married and having their first child is increasing. This trend has increased the number of women seeking the In Vitro Fertilization (IVF) treatment.

Moreover, to focus on their career, many women freeze their eggs to have the child at a later stage. The rising dependence on fertility treatments will support market growth. Availability of funds is leading to a rise in the adoption of IVF procedures. To increase the success rate of IVF, techniques such as Testicular Sperm Extraction (PESA and TESE), are being introduced along with the development of new products. In June 2018, an Australian scientist developed an Artificial Intelligence (AI) tool called Ivy for the identification of an embryo with the best chance of pregnancy. PICSI (Physiological Intra-cytoplasmic Sperm Injection) is one of the techniques of sperm selection and is recommended for couples with a history of miscarriages, low embryo quality, and low fertility. Such technologies help increase the success rate of IVF pregnancies.

COVID-19 in vitro fertilization market impact: 34.6% increase from 2020 to 2021

To compete in the modern business environment, it is crucial for all organizations (manufacturers, clinics, and hospitals) to develop their virtual presence to increase awareness about infertility, infertility treatment, and their services. As infertility is a sensitive issue, people are reluctant to discuss it openly, particularly in developing countries. Hence, developing authenticity and trust through digital platforms is a key challenge for service providers. The providers can take an initial step to gain a center’s or manufacturers’ trust by displaying the hospital’s or approval committee’s certificates, introducing the doctors or scientists, and sharing their coordinates to establish and authenticate their identity.

Instrument Insights

The culture media segment dominated the market for IVF and accounted for a revenue share of more than 40.0% in 2022. This growth was credited to the factors, such as the availability of funding and an increase in research activities to improve the culture media. On the other hand, as industry players are introducing disposable devices, such as needles, slides, and chambers, to meet the sterility and regulatory requirements, Disposable devices are estimated to be the fastest-growing segment with CAGR of 5.33%.

For instance, in May 2017, CrossBay Medical Inc. received U.S. FDA approval for its CrossBay IVF Embryo Transfer catheter set. The product has also received commercialization approval in Europe and China. CrossBay IVF Embryo Transfer Catheter Set is a sterile, disposable device that is used to transfer an in vitro fertilized embryo to the uterus. Such developments are expected to increase the adoption of disposable IVF devices. Disposable slides for sperm counting, an imaging-based tracking system to isolate the best motile sperm, and the use of disposable microchips are some of the innovations witnessed by the market for IVF in recent years.

Procedure Type Insights 

The frozen non-donor segment led the IVF market and accounted for the largest revenue share of 47.7% in 2022. The segment is expected to register the fastest growth over the forecast period. Certain factors contributing to the high share are the cost-effectiveness as compared to fresh non-donor and the less-invasive nature of the procedure. The fresh non-donor segment accounted for the second-highest revenue share in 2021.

The introduction of the vitrification process by the International Federation of Fertility Societies has made sperm donation possible even for HIV-positive patients. The process involves directly isolating the sperm from the plasma. ICSI allows individuals with azoospermia to conceive. As age increases, the chance of success with IVF decreases and is relatively low in women over 40 years of age. Hence, donor eggs are widely used in this section. The shared donor egg program allows single donors to donate eggs to more than one recipient, without compromising the fertility rate. This program is cost-effective for the recipient as well. 

End-use Insights 

The fertility clinics segment dominated the market for IVF and accounted for the largest revenue share of more than 79.0% in 2021. The segment is likely to witness the fastest CAGR from 2022 to 2030. With a rise in demand for ART treatments, the number of fertility clinics and ART centers is increasing considerably. Factors, such as cost-effectiveness, availability of specialists, and minimal or no chances of Hospital-acquired Infections (HAIs), are anticipated to drive the growth of fertility clinics. IVF treatments are also performed in hospitals.

Several multispecialty hospitals offer infertility treatments, including IVF. Increased accessibility and availability of potential treatments can be attributed to a higher preference for hospitals for infertility treatments. The IVF treatments offered by hospitals are generally more expensive than fertility clinics. IVF treatments require highly skilled physicians and staff. Hence, employing a dedicated staff for IVF in hospitals is a less preferable approach. Employment, remuneration, and training are expensive in developed countries, such as the U.S. and U.K. All these abovementioned factors can be attributed to the low share of the hospital segment in the market.

Regional Insights

Europe dominated the in vitro fertilization market and accounted for the largest revenue share of more than 36.98% in 2022. Factors, such as rising medical tourism and legal revisions related to IVF techniques, will propel the regional market growth during the forecast years. An increasing number of people from the U.S. are traveling to the Czech Republic to avail of IVF treatments at lower costs. As per an ESHRE fact sheet, in January 2017, some reimbursement is available for ART in almost all EU member states (except Lithuania and Ireland). In Asia Pacific, the market for IVF is estimated to register the fastest CAGR of 7.29% from 2023 to 2030.

The demand for IVF treatment is expected to boom in the Asia Pacific region due to fertility tourism, increasing foreign investment to penetrate economically developing countries, and the changing regulatory landscape. Incidence of infertility has increased due to changes in lifestyles, such as the increased prevalence of obesity and stress, lack of exercise, improper eating habits, lack of nutrition, and rise in pollution, as well as due to prevalence of medical conditions such as diabetes. North America is also expected to witness increasing demand for fertility treatment in the coming years. Standardization of procedures through automation, regulatory reforms, government funding for egg/sperm storage, and the introduction of more IVF treatments by industry players are among the major factors contributing to the growth of the IVF market in North America.

Key Companies & Market Share Insights

Geographical expansions, mergers, product innovations, and commercialization are the key strategies adopted by the market players. For instance, in July 2019, Vitrolife and Prime Tech entered into a collaboration agreement to design and market the Piezo technique for better Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except for Thailand, Japan, and Malaysia. Some of the prominent players in the in vitro fertilization market include:

• OvaScience

• EMD Serono Inc.

• Vitrolife AB

• Irvine Scientific

• Cook Medical Inc

• Cooper Surgical Inc.

• Genea Biomedx

• Thermo Fisher Scientific Inc.

• Progyny, Inc.

• Boston IVF 

In Vitro Fertilization Market Report Scope

Global In Vitro Fertilization Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global in vitro fertilization market report based on instrument, procedure type, end-use, and region:

• Instrument Outlook (Revenue, USD Million, 2017 - 2030)

  • Disposable Devices

  • Culture Media

  • Capital Equipment

• Procedure Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Fresh Donor

  • Frozen Donor

  • Fresh Non-donor

  • Frozen Non-donor

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Fertility Clinics

  • Hospitals & Other Setting

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • France

    • Germany

    • Italy

    • Spain

    • U.K.

    • Belgium

    • Netherlands

    • Switzerland

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE